DR. ELIZABETH JACOBS, MD
Osteopathic Medicine in Milwaukee, WI

License number

Wisconsin 30127

Personal information

See more information about ELIZABETH JACOBS at radaris.com

Name

Address

Phone

Elizabeth Jacobs

5431 S Whitnall Ave, Cudahy, WI 53110

(414) 303-8184

Elizabeth Jacobs, age 59

3404 Tallyho Ln, Madison, WI 53705

Elizabeth K Jacobs

5431 Whitnall Ave, Cudahy, WI 53110

(414) 747-1572

Elizabeth K Jacobs

3750 Squire Ave, Cudahy, WI 53110

(414) 483-5143

Elizabeth K Jacobs

1812 61St St, Milwaukee, WI 53214

(414) 604-8211

Organization information

See more information about ELIZABETH JACOBS at bizstanding.com

Elizabeth Jacobs MD

9200 W Wisconsin Ave, Milwaukee, WI 53226

Industry:

Internist

Phone:

(414) 805-3666 (Phone)

Elizabeth Rogers Jacobs

Professional information

See more information about ELIZABETH JACOBS at trustoria.com

Dr. Elizabeth Jacobs, Milwaukee WI - MD (Doctor of Medicine)

Specialties:

Pulmonology

Address:

9200 W Wisconsin Ave, Milwaukee 53226
(414) 805-3666 (Phone)

Certifications:

Internal Medicine, 1980, Pulmonary Disease, 1982

Awards:

Healthgrades Honor Roll

Languages:

English, French

Hospitals:

9200 W Wisconsin Ave, Milwaukee 53226
Froedtert Health - Froedtert Hospital
9200 West Wisconsin Ave, Milwaukee 53226

Education:

Medical School
University Of Kansas School Of Medicine
Graduated: 1977

Professor And Chief, Pulmonary And Critical Care Medicine At Medical College Of Wisconsin

Position:

Professor and Chief, Pulmonary and Critical Care Medicine at Medical College of Wisconsin

Location:

Greater Milwaukee Area

Industry:

Research

Work:

Medical College of Wisconsin - Professor and Chief, Pulmonary and Critical Care Medicine

Elizabeth R Jacobs, Milwaukee WI

Specialties:

Pulmonologist

Address:

9200 W Wisconsin Ave, Milwaukee, WI 53226

Education:

University of Kansas, School of Medicine - Doctor of Medicine

Board certifications:

American Board of Internal Medicine Certification in Internal Medicine, American Board of Internal Medicine Sub-certificate in Pulmonary Disease (Internal Medicine)

20-Hete Antagonists And Agonists

US Patent:

6596769, Jul 22, 2003

Filed:

Dec 14, 2001

Appl. No.:

10/021973

Inventors:

Richard J. Roman - Brookfield WI
John R. Falck - Dallas TX
Magdalena Alonso-Galicia - New Berlin WI
Elizabeth R. Jacobs - Milwaukee WI
David R. Harder - Waukesha WI

Assignee:

MCW Research Foundation - Milwaukee WI

International Classification:

A61K 3120

US Classification:

514560, 514381, 514382, 514417, 514423, 514558, 514559, 514601, 514602, 514604, 514605, 514613, 514616, 514713, 514675, 514627, 514678, 514731, 514733, 514738, 514739, 514826, 514866, 514671, 514603

Abstract:

20-HETE agonists and antagonists are disclosed along with therapeutic applications. In a preferable form of the invention, the 20-HETE agonists are selected from the group consisting of 21-hydroxyheneicosa-5(Z),8(Z),11(Z),14(Z)-tetraenoic acid, 20-hydroxyeicosa-5(Z),4(Z)-dienoic acid and 20-,21-dimethyl 20-HETE. Preferable 20-HETE antagonists include 5(S)-HETE, 15(S)-HETE, 19(S)-HETE, 19-hydroxynonadeca-5(Z),8(Z),11(Z),14(Z)-tetraenoic acid and 20-hydroxyeicosa 6(Z),15(Z)-dienoic acid.

20-Hete Antagonists And Agonists

US Patent:

6395781, May 28, 2002

Filed:

Feb 23, 1999

Appl. No.:

09/259414

Inventors:

Richard J. Roman - Brookfield WI
John R. Falck - Dallas TX
Magdalena Alonso-Galicia - New Berlin WI
Elizabeth R. Jacobs - Milwaukee WI
David R. Harder - Waukesha WI

Assignee:

MCW Research Foundation - Milwaukee WI

International Classification:

A61K 3120

US Classification:

514560, 514381, 514382, 514417, 514423, 514558, 514559, 514601, 514602, 514603, 514604, 514605, 514613, 514616, 514671, 514675, 514678, 514706, 514713, 514731, 514733, 514738, 514739, 514627, 514826, 514866

Abstract:

20-HETE agonists and antagonists are disclosed along with therapeutic applications. In a preferable form of the invention, the 20-HETE agonists are selected from the group consisting of 21-hydroxyheneicosa-5(Z),8(Z),11(Z),14(Z)-tetraenoic acid, 20-hydroxyeicosa-5(Z),14(Z)-dienoic acid and 20-,21-dimethyl 20-HETE. Preferable 20-HETE antagonists include 5(S)-HETE, 15(S)-HETE, 19(S)-HETE, 19-hydroxynonadeca-5(Z),8(Z),11(Z),14(Z)-tetraenoic acid and 20-hydroxyeicosa 6(Z),15(Z)-dienoic acid.

20-Hete Antagonists And Agonists

US Patent:

6605641, Aug 12, 2003

Filed:

Dec 14, 2001

Appl. No.:

10/017409

Inventors:

Richard J. Roman - Brookfield WI
John R. Falck - Dallas TX
Magdalena Alonso-Galicia - New Berlin WI
Elizabeth R. Jacobs - Milwaukee WI
David R. Harder - Waukesha WI

Assignee:

MCW Research Foundation - Milwaukee WI

International Classification:

A61K 3120

US Classification:

514560, 514554, 514558, 514601, 514602, 514604, 514605, 514706, 514713, 514613, 514616, 514627, 514675, 514678, 514731, 514733, 514738, 514739, 514826, 514866, 514671, 514381, 514382, 514417, 514423

Abstract:

20-HETE agonists and antagonists are disclosed along with therapeutic applications. In a preferable form of the invention, the 20-HETE agonists are selected from the group consisting of 21-hydroxyheneicosa-5(Z), 8(Z), 11(Z), 14(Z)-tetraenoic acid, 20-hydroxyeicosa-5(Z), 14(Z)-dienoic acid and 20-, 21-dimethyl 20-HETE. Preferable 20-HETE antagonists include 5(S)-HETE, 15(S)-HETE, 19(S)-HETE, 19-hydroxynonadeca-5(Z), 8(Z), 11(Z), 14(Z)-tetraenoic acid and 20-hydroxyeicosa 6(Z), 15(Z)-dienoic acid.